Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34822| Title: | The safety and efficacy of dual biological therapy: Dupilumab and fremanezumab. | Austin Authors: | Honigman, Anthony;Oo, Hnin P;Macdonell, Richard A L ;Kern, Johannes S | Affiliation: | Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Neurology Faculty of Medicine, Dentistry and Health Services, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.;Department of Dermatology, Alfred Health, Melbourne, Victoria, Australia.;Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia. Faculty of Medicine, Dentistry and Health Sciences, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia. |
Issue Date: | 8-Jan-2024 | Date: | 2024 | Publication information: | The Australasian Journal of Dermatology 2024-01-08 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/34822 | DOI: | 10.1111/ajd.14205 | ORCID: | 0000-0002-4872-6340 0000-0003-2440-5128 0000-0001-6604-3968 0000-0001-6372-8048 |
Journal: | The Australasian Journal of Dermatology | PubMed URL: | 38189530 | ISSN: | 1440-0960 | Type: | Journal Article | Subjects: | biologic therapy atopic dermatitis biologic therapy migrane combined biologic therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.